Insider Transactions in Q4 2021 at Oyster Point Pharma, Inc. (OYST)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-49.95%
|
-
|
|
Dec 21
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-49.95%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
120
+1.08%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Dec 21
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
6,838
+19.26%
|
-
|
|
Nov 01
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,590
+12.86%
|
$94,490
$11.51 P/Share
|
|
Oct 21
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.08%
|
$50,000
$1.02 P/Share
|
|
Oct 18
2021
|
Clare Ozawa Director |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|
|
Oct 18
2021
|
William J Phd Link Director |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|
|
Oct 18
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
550,000
-22.86%
|
$7,700,000
$14.86 P/Share
|